Haemonetics Corporation

HAENYSE • USD
104.68 USD
↗ 0.31 (0.30%)AT CLOSE (03:59 PM EDT)
104.46
↘ 0.23 (0.22%)
POST MARKET (AS OF 07:45 PM EDT)
Post Market
AS OF 07:45 PM EDT
104.46
↘ 0.23 (0.22%)
🔴Market: CLOSED

Haemonetics Corporation (HAE) is currently trading at $104.68. Technical and fundamental signals align bullish — technicals rate "Buy" while fundamentals indicate "Buy". This is driven by a robust Altman Z-Score and a bullish Golden Cross on the moving averages. On valuation, HAE trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 2, 2026.

Open?$104.58
High?$105.70
Low?$103.61
Prev. Close?$104.37
Volume?332.9K
Avg. Volume?573.3K
VWAP?$104.85
Rel. Volume?0.58x
Bid / Ask
Bid?$52.51 × 100
Ask?$110.00 × 200
Spread?$57.49
Midpoint?$81.26
Valuation & Ratios
Market Cap?4.8B
Shares Out?45.5M
Float?44.5M
Float %?97.9%
P/E Ratio?49.46
P/B Ratio?5.69
EPS?$2.12
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Employees
3.0K
Market Cap
4.7B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
1991-05-09
Address
125 SUMMER STREET
BOSTON, MA 02110
Phone: (781) 848-7100
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
75
Momentum?
90
Short Sent.?
30
Piotroski F-Score?5/9Mixed
Altman Z-Score?3.13Safe
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?7.69%Elevated
Short Interest?3.4M
Days to Cover?5.7
Free Float44.5M
Avg Daily Volume602.1K
Settlement Date2026-09-15
Financial Health
Current Ratio?3.08Strong
Quick Ratio?1.91Adequate
Cash Ratio?0.85Adequate
Debt/Equity?1.40Moderate
ValuationFAIRLY VALUEDvs 8 peers + S&P 500
Score
67/100
P/E?
Peers
29
S&P
13
49.5PRICEY▾
P/B?
Peers
44
S&P
33
5.69FAIR▾
P/S?
Peers
67
S&P
44
3.52FAIR▾
P/FCF?
Peers
57
S&P
57
19.4CHEAP▾
EV/EBITDA?
Peers
57
S&P
43
16.1FAIR▾
EV/Sales?
Peers
44
S&P
44
4.23FAIR▾
Returns & Efficiency
ROE?
Peers
43
S&P
41
11.5%FAIR▾
ROA?
Peers
29
S&P
37
4.1%FAIR▾
Cash Flow & Enterprise
FCF?$245.2M
Enterprise Value?$5.7B
Fundamentals ratios updated end of day